Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Guy Ungerechts

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3961-2368; OpenAlex author ID A5114239057. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 7

  1. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures. Co-author DOI 10.1016/j.ebiom.2024.105219↗
  2. Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model. Co-author DOI 10.3389/fimmu.2022.1096162↗
  3. MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer. Last author DOI 10.1016/j.omto.2021.04.015↗
  4. Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcino… Last author DOI 10.1158/1078-0432.ccr-21-1020↗
  5. A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pan… Last author DOI 10.1186/s12885-017-3604-y↗
  6. Gene and cell therapy for pancreatic cancer. First author DOI 10.1517/14712598.2015.1001734↗
  7. Armed and targeted measles virus for chemovirotherapy of pancreatic cancer. Last author DOI 10.1038/cgt.2011.30↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christine E. Engeland · 5 shared papers, 2017–2024 · strength 0.56
  2. Claudia R. Ball · 2 shared papers, 2022–2024 · strength 0.28
  3. Theresa E. Schäfer · 2 shared papers, 2022–2024 · strength 0.28
  4. Hans Martin Singh · 2 shared papers, 2015–2021 · strength 0.21
  5. Albrecht Stenzinger · 2 shared papers, 2017–2022 · strength 0.19
  6. Niels Halama · 2 shared papers, 2017–2021 · strength 0.15
  7. Assia L. Angelova · 2 shared papers, 2017–2021 · strength 0.15
  8. Christoph Springfeld · 2 shared papers, 2017–2021 · strength 0.15
  9. Jacek Hajda · 2 shared papers, 2017–2021 · strength 0.15
  10. Sascha Bossow · 2 shared papers, 2011–2021 · strength 0.15
  11. Florian Gebauer · 1 shared paper, 2024 · strength 0.15
  12. Rob C. Hoeben · 1 shared paper, 2024 · strength 0.15
  13. Lukas J.A.C. Hawinkels · 1 shared paper, 2024 · strength 0.15
  14. Selas T. F. Bots · 1 shared paper, 2024 · strength 0.15
  15. Vera Kemp · 1 shared paper, 2024 · strength 0.15
  16. Rūta Veinalde · 1 shared paper, 2022 · strength 0.14
  17. Nicolas Hohmann · 1 shared paper, 2021 · strength 0.10
  18. Matthias M. Gaida · 1 shared paper, 2021 · strength 0.10
  19. Apostolia Maria Tsimberidou · 1 shared paper, 2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.